Key facts
- Notable investors include Transpose Platform Management, Masayoshi Son, Samuel Altman.
- Status: Privately Held (backing).
- ·The complete investor list — 3 names
- ·Watchlist + deal alerts for Episteme
- ·The full record, as it builds
Funding rounds
No funding rounds for Episteme are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Episteme
Provider of scientific research and development services intended to support long-term translational science across multiple disciplines. The company offers research that deals with intellectual property concerns, tax issues, hiring, and other day-to-day support functions, enabling researchers to pursue scientific investigations and breakthroughs.
- Sector
- Business Products and Services (B2B)
- HQ
- San Francisco, CA, United States
- Founded
- 2021
- Website
- episteme.com/
- Ownership
- Privately Held (backing)
Episteme doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Episteme shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Episteme in its N-PORT filings yet. We sweep new filings monthly.